

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of gene silencing by RNA (GO:0060966) | 8.28845110 |
| 2 | regulation of posttranscriptional gene silencing (GO:0060147) | 8.28845110 |
| 3 | regulation of gene silencing by miRNA (GO:0060964) | 8.28845110 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.71291107 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.71291107 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.50613711 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.50613711 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.32820947 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.01212028 |
| 10 | L-serine metabolic process (GO:0006563) | 5.93712120 |
| 11 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.71413038 |
| 12 | pre-miRNA processing (GO:0031054) | 5.58212671 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.46647553 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.45128276 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.45128276 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.45128276 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.44831677 |
| 18 | urea cycle (GO:0000050) | 5.39512924 |
| 19 | urea metabolic process (GO:0019627) | 5.39512924 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.20909857 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.20654367 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.16927723 |
| 23 | tryptophan metabolic process (GO:0006568) | 5.14979533 |
| 24 | cysteine metabolic process (GO:0006534) | 5.11308226 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07532607 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04926608 |
| 27 | protein carboxylation (GO:0018214) | 5.04926608 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.03092516 |
| 29 | phospholipid efflux (GO:0033700) | 4.99273815 |
| 30 | regulation of cell fate specification (GO:0042659) | 4.96548259 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.96391529 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.93462907 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.92645548 |
| 34 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 4.92579916 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.90573099 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.86138295 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.85132609 |
| 38 | complement activation, alternative pathway (GO:0006957) | 4.79733438 |
| 39 | establishment of integrated proviral latency (GO:0075713) | 4.77128979 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.71509178 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.70237288 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.70237288 |
| 43 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 4.68081539 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.63421193 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.63421193 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63421193 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.62820062 |
| 48 | protein complex localization (GO:0031503) | 4.56576399 |
| 49 | bile acid metabolic process (GO:0008206) | 4.54037520 |
| 50 | regulation of complement activation (GO:0030449) | 4.53393131 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.49003451 |
| 52 | heterochromatin organization (GO:0070828) | 4.41957318 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.41286201 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.41286201 |
| 55 | intestinal cholesterol absorption (GO:0030299) | 4.39711300 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.36546514 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 4.34379550 |
| 58 | cholesterol efflux (GO:0033344) | 4.29845051 |
| 59 | cellular glucuronidation (GO:0052695) | 4.28433708 |
| 60 | lysine catabolic process (GO:0006554) | 4.28143794 |
| 61 | lysine metabolic process (GO:0006553) | 4.28143794 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.26493494 |
| 63 | regulation of gene silencing (GO:0060968) | 4.24598330 |
| 64 | paraxial mesoderm development (GO:0048339) | 4.24023199 |
| 65 | tyrosine metabolic process (GO:0006570) | 4.21208309 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 4.20074506 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.17658397 |
| 68 | glycine metabolic process (GO:0006544) | 4.13464241 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.12697053 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.10434333 |
| 71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.10434333 |
| 72 | drug catabolic process (GO:0042737) | 4.09815382 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 4.09751310 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 4.07675240 |
| 75 | fibrinolysis (GO:0042730) | 4.00933380 |
| 76 | negative regulation of gene silencing (GO:0060969) | 3.99226918 |
| 77 | regulation of histone H3-K9 methylation (GO:0051570) | 3.94558772 |
| 78 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.93607720 |
| 79 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.93607720 |
| 80 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.93607720 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.91791543 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 3.90660830 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87984879 |
| 84 | glutamate metabolic process (GO:0006536) | 3.87161194 |
| 85 | sterol homeostasis (GO:0055092) | 3.86496593 |
| 86 | regulation of helicase activity (GO:0051095) | 3.84857637 |
| 87 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.83535083 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.82500912 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81927371 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.81723101 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.81723101 |
| 92 | lung-associated mesenchyme development (GO:0060484) | 3.81534415 |
| 93 | protein-lipid complex assembly (GO:0065005) | 3.81115928 |
| 94 | nuclear pore complex assembly (GO:0051292) | 3.81072549 |
| 95 | protein localization to kinetochore (GO:0034501) | 3.80743126 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.79354882 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.78761060 |
| 98 | ethanol oxidation (GO:0006069) | 3.77249975 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.76849743 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.76792717 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 3.76397236 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 3.75596533 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.72581867 |
| 104 | cellular biogenic amine catabolic process (GO:0042402) | 3.71809068 |
| 105 | amine catabolic process (GO:0009310) | 3.71809068 |
| 106 | positive regulation of catenin import into nucleus (GO:0035413) | 3.70069352 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.68376063 |
| 108 | regulation of chromatin silencing (GO:0031935) | 3.66847410 |
| 109 | arginine metabolic process (GO:0006525) | 3.66029995 |
| 110 | cellular ketone body metabolic process (GO:0046950) | 3.65535331 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.63851821 |
| 112 | plasma lipoprotein particle organization (GO:0071827) | 3.60958925 |
| 113 | response to nitrosative stress (GO:0051409) | 3.60755881 |
| 114 | establishment of apical/basal cell polarity (GO:0035089) | 3.59870645 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.59123968 |
| 116 | aldehyde catabolic process (GO:0046185) | 3.54590898 |
| 117 | negative regulation of cell fate specification (GO:0009996) | 3.54582218 |
| 118 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.54081367 |
| 119 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.54081367 |
| 120 | intestinal absorption (GO:0050892) | 3.53918548 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52388445 |
| 122 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.51041784 |
| 123 | regulation of cell fate commitment (GO:0010453) | 3.48561293 |
| 124 | coenzyme catabolic process (GO:0009109) | 3.47827898 |
| 125 | establishment of viral latency (GO:0019043) | 3.47690764 |
| 126 | dorsal/ventral axis specification (GO:0009950) | 3.46778356 |
| 127 | protein-lipid complex subunit organization (GO:0071825) | 3.42151724 |
| 128 | IMP biosynthetic process (GO:0006188) | 3.41547165 |
| 129 | single strand break repair (GO:0000012) | 3.41376672 |
| 130 | nuclear pore organization (GO:0006999) | 3.40983698 |
| 131 | drug metabolic process (GO:0017144) | 3.40081479 |
| 132 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36651119 |
| 133 | acute-phase response (GO:0006953) | 3.35350955 |
| 134 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.34509640 |
| 135 | blood coagulation, intrinsic pathway (GO:0007597) | 3.34098759 |
| 136 | protein activation cascade (GO:0072376) | 3.33580256 |
| 137 | negative regulation of telomerase activity (GO:0051974) | 3.33162047 |
| 138 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.32683012 |
| 139 | gap junction assembly (GO:0016264) | 3.32355780 |
| 140 | complement activation (GO:0006956) | 3.32312721 |
| 141 | negative regulation of cell fate commitment (GO:0010454) | 3.28798454 |
| 142 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.28717194 |
| 143 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.28717194 |
| 144 | glomerular visceral epithelial cell development (GO:0072015) | 3.26820097 |
| 145 | histone arginine methylation (GO:0034969) | 3.25362709 |
| 146 | cellular protein complex localization (GO:0034629) | 3.23002683 |
| 147 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.22966867 |
| 148 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.22966867 |
| 149 | IMP metabolic process (GO:0046040) | 3.19568651 |
| 150 | telomere maintenance via telomerase (GO:0007004) | 3.16256424 |
| 151 | DNA unwinding involved in DNA replication (GO:0006268) | 3.16111354 |
| 152 | chromatin remodeling at centromere (GO:0031055) | 3.14287523 |
| 153 | negative regulation of histone methylation (GO:0031061) | 3.13987372 |
| 154 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.10307036 |
| 155 | nucleobase biosynthetic process (GO:0046112) | 3.10254176 |
| 156 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.09263021 |
| 157 | anterior/posterior axis specification, embryo (GO:0008595) | 3.08417963 |
| 158 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.08225010 |
| 159 | convergent extension (GO:0060026) | 3.02550469 |
| 160 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.96448676 |
| 161 | establishment of monopolar cell polarity (GO:0061162) | 2.96448676 |
| 162 | regulation of stem cell maintenance (GO:2000036) | 2.96115592 |
| 163 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.95131654 |
| 164 | negative regulation of sister chromatid segregation (GO:0033046) | 2.95131654 |
| 165 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.95131654 |
| 166 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.95131654 |
| 167 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.95131654 |
| 168 | nodal signaling pathway (GO:0038092) | 2.93277081 |
| 169 | DNA strand elongation (GO:0022616) | 2.91994706 |
| 170 | DNA replication checkpoint (GO:0000076) | 2.91873370 |
| 171 | negative regulation of chromosome segregation (GO:0051985) | 2.91756283 |
| 172 | CENP-A containing nucleosome assembly (GO:0034080) | 2.91093118 |
| 173 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.88518684 |
| 174 | purine nucleobase biosynthetic process (GO:0009113) | 2.85713505 |
| 175 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.82826747 |
| 176 | notochord development (GO:0030903) | 2.82558713 |
| 177 | histone exchange (GO:0043486) | 2.82336817 |
| 178 | chromatin assembly (GO:0031497) | 2.79742982 |
| 179 | glomerular epithelial cell development (GO:0072310) | 2.77613138 |
| 180 | regulation of translational fidelity (GO:0006450) | 2.74748442 |
| 181 | glutamine metabolic process (GO:0006541) | 2.73368587 |
| 182 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.73342698 |
| 183 | DNA replication-independent nucleosome organization (GO:0034724) | 2.73342698 |
| 184 | ribosome assembly (GO:0042255) | 2.72685118 |
| 185 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.72525145 |
| 186 | ncRNA catabolic process (GO:0034661) | 2.71465934 |
| 187 | RNA-dependent DNA replication (GO:0006278) | 2.70863812 |
| 188 | regulation of chromosome segregation (GO:0051983) | 2.70631000 |
| 189 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.70300886 |
| 190 | basic amino acid transport (GO:0015802) | 2.67626055 |
| 191 | protein localization to chromosome, centromeric region (GO:0071459) | 2.67246780 |
| 192 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.67106930 |
| 193 | DNA damage response, detection of DNA damage (GO:0042769) | 2.66322721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.41115591 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.23625220 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.45929020 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.83717647 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.68344187 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.09225105 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47451091 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.40689405 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.27258382 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.55677219 |
| 11 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.55677219 |
| 12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.55677219 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48715179 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.48683756 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.06094196 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84703333 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.80308912 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.78791769 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.67838622 |
| 20 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.60680274 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60413389 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.33773931 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.32376160 |
| 24 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 2.23801624 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.22062869 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18922557 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15475875 |
| 28 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 2.10625085 |
| 29 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.08680060 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08196318 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.04728928 |
| 32 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.03152593 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01157059 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2812109 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.99308216 |
| 36 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.98179306 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.95611692 |
| 38 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.93039035 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88311287 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.84531860 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81571324 |
| 42 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.76265107 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74924917 |
| 44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.73113855 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71157513 |
| 46 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.69579731 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68938739 |
| 48 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.68744529 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67318842 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61579938 |
| 51 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.60840407 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58590863 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55820147 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47240283 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46694387 |
| 56 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46249885 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.43302671 |
| 58 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41747562 |
| 59 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41612303 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40821213 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38916399 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36219523 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.35584920 |
| 64 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.29195043 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29124788 |
| 66 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28343337 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27229917 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27067355 |
| 69 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26389451 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25061241 |
| 71 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.24640677 |
| 72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24129962 |
| 73 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.23093128 |
| 74 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.22806037 |
| 75 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.22090562 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19428560 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18897471 |
| 78 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.17822440 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17252439 |
| 80 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16871992 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16830717 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16625475 |
| 83 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.16576985 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15602493 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14681066 |
| 86 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14470548 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14146082 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12104274 |
| 89 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.12009980 |
| 90 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10075792 |
| 91 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09701981 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09670129 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09429807 |
| 94 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.08622204 |
| 95 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.06623315 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.06015475 |
| 97 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05026575 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04897508 |
| 99 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04644597 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03777584 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02943247 |
| 102 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02856736 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02359705 |
| 104 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.02173014 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01689158 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01524136 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01501242 |
| 108 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01458881 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01188848 |
| 110 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01140335 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01001503 |
| 112 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00329036 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99760197 |
| 114 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99293451 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98311567 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98230064 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.98154067 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97897950 |
| 119 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.97525442 |
| 120 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97296728 |
| 121 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.96642868 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96034503 |
| 123 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94571809 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94471736 |
| 125 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93455164 |
| 126 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93410664 |
| 127 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92925706 |
| 128 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92476656 |
| 129 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91649000 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90995156 |
| 131 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.90981650 |
| 132 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90572360 |
| 133 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90428499 |
| 134 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90204696 |
| 135 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89012871 |
| 136 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88730314 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88647627 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88083155 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86489976 |
| 140 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85331759 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83228069 |
| 142 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81676303 |
| 143 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81676303 |
| 144 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81554260 |
| 145 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81430308 |
| 146 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80676558 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79726239 |
| 148 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79527742 |
| 149 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77175767 |
| 150 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76821052 |
| 151 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76657280 |
| 152 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72087988 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71013481 |
| 154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70389265 |
| 155 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69118729 |
| 156 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68620703 |
| 157 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.67799023 |
| 158 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.67201493 |
| 159 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64056453 |
| 160 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.62792291 |
| 161 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62620953 |
| 162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60321164 |
| 163 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59056304 |
| 164 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.58884631 |
| 165 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58205610 |
| 166 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56995070 |
| 167 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.55956135 |
| 168 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55943486 |
| 169 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54599120 |
| 170 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.54395437 |
| 171 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.53584973 |
| 172 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53564641 |
| 173 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53564641 |
| 174 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.52397891 |
| 175 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.52304247 |
| 176 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.52284547 |
| 177 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.51814200 |
| 178 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.51443728 |
| 179 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.51279701 |
| 180 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.51137435 |
| 181 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.50839308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.26965212 |
| 2 | MP0005360_urolithiasis | 7.23577122 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.66050621 |
| 4 | MP0005365_abnormal_bile_salt | 5.13087734 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.46992425 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.82857866 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70020044 |
| 8 | MP0003252_abnormal_bile_duct | 3.67691665 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.27888678 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.25256117 |
| 11 | MP0009840_abnormal_foam_cell | 3.22654504 |
| 12 | MP0001666_abnormal_nutrient_absorption | 3.04225357 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.75478491 |
| 14 | MP0005083_abnormal_biliary_tract | 2.67628181 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.57115446 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.51538490 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.47728804 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.41878882 |
| 19 | MP0010094_abnormal_chromosome_stability | 2.39746389 |
| 20 | MP0005332_abnormal_amino_acid | 2.37216538 |
| 21 | MP0003878_abnormal_ear_physiology | 2.31681533 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 2.31681533 |
| 23 | MP0008057_abnormal_DNA_replication | 2.30967129 |
| 24 | MP0002796_impaired_skin_barrier | 2.22676810 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.20401485 |
| 26 | MP0008058_abnormal_DNA_repair | 2.18582516 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 2.05893149 |
| 28 | MP0003195_calcinosis | 1.98484028 |
| 29 | MP0001293_anophthalmia | 1.92735610 |
| 30 | MP0000609_abnormal_liver_physiology | 1.91448962 |
| 31 | MP0001730_embryonic_growth_arrest | 1.86874279 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.86010110 |
| 33 | MP0003077_abnormal_cell_cycle | 1.75502674 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.74575185 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.71475569 |
| 36 | MP0000579_abnormal_nail_morphology | 1.66289273 |
| 37 | MP0003119_abnormal_digestive_system | 1.65691442 |
| 38 | MP0003937_abnormal_limbs/digits/tail_de | 1.63553315 |
| 39 | MP0006292_abnormal_olfactory_placode | 1.60163309 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.58576141 |
| 41 | MP0004133_heterotaxia | 1.58246106 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.56026488 |
| 43 | MP0003136_yellow_coat_color | 1.46870744 |
| 44 | MP0002085_abnormal_embryonic_tissue | 1.46475393 |
| 45 | MP0009703_decreased_birth_body | 1.45608963 |
| 46 | MP0002697_abnormal_eye_size | 1.43973316 |
| 47 | MP0001188_hyperpigmentation | 1.43490591 |
| 48 | MP0009053_abnormal_anal_canal | 1.42611952 |
| 49 | MP0005275_abnormal_skin_tensile | 1.39372176 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.38931177 |
| 51 | MP0005380_embryogenesis_phenotype | 1.38931177 |
| 52 | MP0002084_abnormal_developmental_patter | 1.38454167 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.37991866 |
| 54 | MP0005451_abnormal_body_composition | 1.37407256 |
| 55 | MP0003868_abnormal_feces_composition | 1.34652253 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.30437099 |
| 57 | MP0003787_abnormal_imprinting | 1.30016029 |
| 58 | MP0003123_paternal_imprinting | 1.27321129 |
| 59 | MP0005501_abnormal_skin_physiology | 1.27286928 |
| 60 | * MP0002111_abnormal_tail_morphology | 1.25375379 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.19959807 |
| 62 | MP0003984_embryonic_growth_retardation | 1.19417779 |
| 63 | MP0002060_abnormal_skin_morphology | 1.19295157 |
| 64 | MP0001697_abnormal_embryo_size | 1.17520871 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.16679855 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.16469046 |
| 67 | MP0004197_abnormal_fetal_growth/weight/ | 1.16415967 |
| 68 | MP0003186_abnormal_redox_activity | 1.16160062 |
| 69 | MP0001764_abnormal_homeostasis | 1.16052389 |
| 70 | MP0009697_abnormal_copulation | 1.14431466 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.14173286 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11060534 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.09530814 |
| 74 | MP0003011_delayed_dark_adaptation | 1.08594486 |
| 75 | MP0000598_abnormal_liver_morphology | 1.06988568 |
| 76 | MP0002080_prenatal_lethality | 1.05932663 |
| 77 | MP0002938_white_spotting | 1.02033910 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.02032815 |
| 79 | MP0001216_abnormal_epidermal_layer | 0.99273459 |
| 80 | MP0001286_abnormal_eye_development | 0.97471765 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 0.95982823 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.94671252 |
| 83 | MP0000432_abnormal_head_morphology | 0.94413816 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.89082356 |
| 85 | MP0010678_abnormal_skin_adnexa | 0.88916174 |
| 86 | MP0000377_abnormal_hair_follicle | 0.88891188 |
| 87 | MP0000427_abnormal_hair_cycle | 0.88684375 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.88559157 |
| 89 | MP0004947_skin_inflammation | 0.88183531 |
| 90 | MP0009764_decreased_sensitivity_to | 0.88005522 |
| 91 | MP0003941_abnormal_skin_development | 0.87236053 |
| 92 | MP0003121_genomic_imprinting | 0.86181277 |
| 93 | MP0010307_abnormal_tumor_latency | 0.86174141 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.86021507 |
| 95 | MP0000647_abnormal_sebaceous_gland | 0.85435768 |
| 96 | MP0000049_abnormal_middle_ear | 0.83662441 |
| 97 | MP0009763_increased_sensitivity_to | 0.82896248 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.81995455 |
| 99 | MP0000467_abnormal_esophagus_morphology | 0.81858947 |
| 100 | MP0005408_hypopigmentation | 0.81241240 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.80241683 |
| 102 | MP0002233_abnormal_nose_morphology | 0.77839766 |
| 103 | MP0005647_abnormal_sex_gland | 0.76343848 |
| 104 | MP0005023_abnormal_wound_healing | 0.75414867 |
| 105 | MP0001243_abnormal_dermal_layer | 0.74696426 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.73864155 |
| 107 | MP0000604_amyloidosis | 0.72403986 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.72146110 |
| 109 | MP0008469_abnormal_protein_level | 0.71626969 |
| 110 | MP0005410_abnormal_fertilization | 0.71017377 |
| 111 | MP0000627_abnormal_mammary_gland | 0.70946626 |
| 112 | * MP0002254_reproductive_system_inflammat | 0.70895576 |
| 113 | MP0003861_abnormal_nervous_system | 0.70838464 |
| 114 | MP0000490_abnormal_crypts_of | 0.70038587 |
| 115 | MP0000383_abnormal_hair_follicle | 0.69949834 |
| 116 | MP0000313_abnormal_cell_death | 0.69241425 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.68018227 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.67985695 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.67962784 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.67209400 |
| 121 | MP0004233_abnormal_muscle_weight | 0.66497409 |
| 122 | MP0009384_cardiac_valve_regurgitation | 0.65202087 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.64208439 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.64120425 |
| 125 | MP0010771_integument_phenotype | 0.64106811 |
| 126 | MP0009931_abnormal_skin_appearance | 0.62971640 |
| 127 | MP0004381_abnormal_hair_follicle | 0.61254581 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.61167983 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.61073360 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.59652025 |
| 131 | MP0001756_abnormal_urination | 0.58827033 |
| 132 | MP0003436_decreased_susceptibility_to | 0.58795530 |
| 133 | MP0000566_synostosis | 0.58641359 |
| 134 | MP0002971_abnormal_brown_adipose | 0.56472286 |
| 135 | MP0005220_abnormal_exocrine_pancreas | 0.56171935 |
| 136 | MP0010030_abnormal_orbit_morphology | 0.54155858 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.52153076 |
| 138 | MP0003718_maternal_effect | 0.51762477 |
| 139 | MP0001849_ear_inflammation | 0.50972907 |
| 140 | MP0005266_abnormal_metabolism | 0.50906386 |
| 141 | MP0005395_other_phenotype | 0.50865695 |
| 142 | MP0009672_abnormal_birth_weight | 0.50715801 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.49561349 |
| 144 | MP0000367_abnormal_coat/_hair | 0.47887871 |
| 145 | MP0001191_abnormal_skin_condition | 0.47824518 |
| 146 | MP0005334_abnormal_fat_pad | 0.46920616 |
| 147 | MP0000537_abnormal_urethra_morphology | 0.45647657 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.45285020 |
| 149 | MP0000538_abnormal_urinary_bladder | 0.45009938 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.42688677 |
| 151 | MP0000762_abnormal_tongue_morphology | 0.42140761 |
| 152 | MP0003724_increased_susceptibility_to | 0.42020745 |
| 153 | MP0004185_abnormal_adipocyte_glucose | 0.41315139 |
| 154 | MP0001881_abnormal_mammary_gland | 0.41125870 |
| 155 | MP0005448_abnormal_energy_balance | 0.41052652 |
| 156 | MP0005670_abnormal_white_adipose | 0.41005004 |
| 157 | MP0001853_heart_inflammation | 0.40047382 |
| 158 | MP0001661_extended_life_span | 0.39888740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.95963079 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.78925450 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.73336319 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.37807288 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.34811902 |
| 6 | Xanthomatosis (HP:0000991) | 6.08639840 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.71772196 |
| 8 | Hypolipoproteinemia (HP:0010981) | 4.80718591 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.77083802 |
| 10 | Complement deficiency (HP:0004431) | 4.61917090 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.61459636 |
| 12 | Epidermoid cyst (HP:0200040) | 4.44303276 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.28899175 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16406335 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15086278 |
| 16 | Hyperammonemia (HP:0001987) | 4.14839132 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.14018027 |
| 18 | Fat malabsorption (HP:0002630) | 4.12696590 |
| 19 | Colon cancer (HP:0003003) | 4.10930573 |
| 20 | Joint hemorrhage (HP:0005261) | 4.07016327 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93183254 |
| 22 | Hyperglycinuria (HP:0003108) | 3.75986933 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.74057533 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69519431 |
| 25 | Abnormality of complement system (HP:0005339) | 3.61932484 |
| 26 | Hyperglycinemia (HP:0002154) | 3.61054251 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.59282176 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.55200537 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.55200537 |
| 30 | Ketosis (HP:0001946) | 3.53660120 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.49468973 |
| 32 | Selective tooth agenesis (HP:0001592) | 3.49402899 |
| 33 | Abnormality of the labia minora (HP:0012880) | 3.46297419 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.45600375 |
| 35 | Choanal stenosis (HP:0000452) | 3.35036731 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32730533 |
| 37 | Hepatoblastoma (HP:0002884) | 3.32090509 |
| 38 | Ependymoma (HP:0002888) | 3.29836258 |
| 39 | Septo-optic dysplasia (HP:0100842) | 3.29071678 |
| 40 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.22652392 |
| 41 | Bilateral microphthalmos (HP:0007633) | 3.20435438 |
| 42 | Malnutrition (HP:0004395) | 3.14654490 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 3.09888501 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05151719 |
| 45 | Myocardial infarction (HP:0001658) | 2.99106326 |
| 46 | Embryonal renal neoplasm (HP:0011794) | 2.98075041 |
| 47 | Chronic bronchitis (HP:0004469) | 2.97576507 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.94904086 |
| 49 | Vascular calcification (HP:0004934) | 2.93746439 |
| 50 | Absent eyelashes (HP:0000561) | 2.92516314 |
| 51 | Steatorrhea (HP:0002570) | 2.91674935 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.85335319 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82162320 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.72967863 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.72111389 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.71963323 |
| 57 | Esophageal varix (HP:0002040) | 2.68663112 |
| 58 | Acanthocytosis (HP:0001927) | 2.66777024 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.65955034 |
| 60 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.62796766 |
| 61 | Spastic diplegia (HP:0001264) | 2.61093939 |
| 62 | Abnormality of the salivary glands (HP:0010286) | 2.59119625 |
| 63 | Abnormality of the lacrimal duct (HP:0011481) | 2.55820902 |
| 64 | Neoplasm of the adrenal cortex (HP:0100641) | 2.55751982 |
| 65 | Abnormal lung lobation (HP:0002101) | 2.54387748 |
| 66 | Spontaneous abortion (HP:0005268) | 2.53827302 |
| 67 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51657663 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.50380914 |
| 69 | Birth length less than 3rd percentile (HP:0003561) | 2.50271734 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.48638296 |
| 71 | Absent eyebrow (HP:0002223) | 2.47635389 |
| 72 | Abnormality of homocysteine metabolism (HP:0010919) | 2.44763143 |
| 73 | Homocystinuria (HP:0002156) | 2.44763143 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 2.44423284 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.44423284 |
| 76 | Ketoacidosis (HP:0001993) | 2.43734082 |
| 77 | Skin nodule (HP:0200036) | 2.43376990 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.43098742 |
| 79 | Gastrointestinal carcinoma (HP:0002672) | 2.42208641 |
| 80 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.42208641 |
| 81 | Multiple enchondromatosis (HP:0005701) | 2.41148384 |
| 82 | Metabolic acidosis (HP:0001942) | 2.40941044 |
| 83 | Gout (HP:0001997) | 2.40322658 |
| 84 | Chromsome breakage (HP:0040012) | 2.39795105 |
| 85 | Bronchomalacia (HP:0002780) | 2.35125182 |
| 86 | Breast carcinoma (HP:0003002) | 2.31684378 |
| 87 | Myelomeningocele (HP:0002475) | 2.30461707 |
| 88 | Absent hair (HP:0002298) | 2.29405854 |
| 89 | Clitoromegaly (HP:0000057) | 2.27555815 |
| 90 | Alopecia of scalp (HP:0002293) | 2.25623071 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 2.25332856 |
| 92 | Biliary tract neoplasm (HP:0100574) | 2.24884644 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.24043423 |
| 94 | Facial cleft (HP:0002006) | 2.23482215 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.22669362 |
| 96 | Neonatal onset (HP:0003623) | 2.22440746 |
| 97 | Cholelithiasis (HP:0001081) | 2.21596380 |
| 98 | Uterine neoplasm (HP:0010784) | 2.20707509 |
| 99 | Meckel diverticulum (HP:0002245) | 2.20320475 |
| 100 | Oral leukoplakia (HP:0002745) | 2.19230331 |
| 101 | Woolly hair (HP:0002224) | 2.18056605 |
| 102 | Bifid tongue (HP:0010297) | 2.17646115 |
| 103 | Stenosis of the external auditory canal (HP:0000402) | 2.16591344 |
| 104 | Fragile nails (HP:0001808) | 2.14697908 |
| 105 | Amyloidosis (HP:0011034) | 2.13804820 |
| 106 | Pendular nystagmus (HP:0012043) | 2.13398706 |
| 107 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.11870593 |
| 108 | Skull defect (HP:0001362) | 2.11316499 |
| 109 | Maternal diabetes (HP:0009800) | 2.11247913 |
| 110 | Glomerulonephritis (HP:0000099) | 2.10692460 |
| 111 | Rhabdomyosarcoma (HP:0002859) | 2.10625125 |
| 112 | Lethargy (HP:0001254) | 2.10179189 |
| 113 | Hypoplastic female external genitalia (HP:0012815) | 2.10030104 |
| 114 | Sparse eyelashes (HP:0000653) | 2.09754116 |
| 115 | Late onset (HP:0003584) | 2.09378867 |
| 116 | Rickets (HP:0002748) | 2.08927499 |
| 117 | Abnormality of the ileum (HP:0001549) | 2.08695032 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.08631086 |
| 119 | Dicarboxylic aciduria (HP:0003215) | 2.06874511 |
| 120 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06874511 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 2.06628962 |
| 122 | Cholecystitis (HP:0001082) | 2.06628962 |
| 123 | Abnormality of the preputium (HP:0100587) | 2.06546192 |
| 124 | Abnormality of the nasolacrimal system (HP:0000614) | 2.06513576 |
| 125 | Pancreatitis (HP:0001733) | 2.05858496 |
| 126 | Pterygium (HP:0001059) | 2.03149715 |
| 127 | Short hallux (HP:0010109) | 2.02535763 |
| 128 | Increased mean platelet volume (HP:0011877) | 2.02505811 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.01131599 |
| 130 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.01131599 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 2.01081225 |
| 132 | Labial hypoplasia (HP:0000066) | 2.00945016 |
| 133 | Plantar hyperkeratosis (HP:0007556) | 1.99949956 |
| 134 | Impulsivity (HP:0100710) | 1.99170997 |
| 135 | Carpal bone hypoplasia (HP:0001498) | 1.99028082 |
| 136 | Mitral stenosis (HP:0001718) | 1.98611732 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98406482 |
| 138 | Esophageal atresia (HP:0002032) | 1.98271049 |
| 139 | Symptomatic seizures (HP:0011145) | 1.97438279 |
| 140 | Irritability (HP:0000737) | 1.96522206 |
| 141 | Breast aplasia (HP:0100783) | 1.95361761 |
| 142 | Absent radius (HP:0003974) | 1.94794878 |
| 143 | Abnormality of the clitoris (HP:0000056) | 1.94178694 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.92399846 |
| 145 | Scrotal hypoplasia (HP:0000046) | 1.92371099 |
| 146 | Poikilocytosis (HP:0004447) | 1.92222078 |
| 147 | Gingival bleeding (HP:0000225) | 1.91950333 |
| 148 | Vaginal fistula (HP:0004320) | 1.91692698 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90299355 |
| 150 | Ileus (HP:0002595) | 1.89728514 |
| 151 | Embryonal neoplasm (HP:0002898) | 1.89529650 |
| 152 | Menorrhagia (HP:0000132) | 1.89147129 |
| 153 | Cellular immunodeficiency (HP:0005374) | 1.87985591 |
| 154 | Abnormality of the septum pellucidum (HP:0007375) | 1.87911617 |
| 155 | Neoplasm of the colon (HP:0100273) | 1.87787347 |
| 156 | Nephritis (HP:0000123) | 1.87078790 |
| 157 | Abnormal hair laboratory examination (HP:0003328) | 1.86934134 |
| 158 | Pili torti (HP:0003777) | 1.86022739 |
| 159 | Reticulocytosis (HP:0001923) | 1.84863507 |
| 160 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.84004709 |
| 161 | Hypophosphatemic rickets (HP:0004912) | 1.83831069 |
| 162 | Proximal tubulopathy (HP:0000114) | 1.83113083 |
| 163 | Abnormality of chromosome stability (HP:0003220) | 1.82941648 |
| 164 | Palmoplantar hyperkeratosis (HP:0000972) | 1.82671240 |
| 165 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.81942962 |
| 166 | Onycholysis (HP:0001806) | 1.81625630 |
| 167 | Cleft eyelid (HP:0000625) | 1.81461932 |
| 168 | Back pain (HP:0003418) | 1.81385453 |
| 169 | Generalized aminoaciduria (HP:0002909) | 1.81196890 |
| 170 | Absent forearm bone (HP:0003953) | 1.80440177 |
| 171 | Aplasia involving forearm bones (HP:0009822) | 1.80440177 |
| 172 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.80286572 |
| 173 | Abnormality of the gallbladder (HP:0005264) | 1.78996756 |
| 174 | Absent septum pellucidum (HP:0001331) | 1.77857786 |
| 175 | Thrombophlebitis (HP:0004418) | 1.77560842 |
| 176 | Cutaneous syndactyly (HP:0012725) | 1.77332907 |
| 177 | Partial duplication of thumb phalanx (HP:0009944) | 1.76806112 |
| 178 | Synostosis involving the elbow (HP:0003938) | 1.76765187 |
| 179 | Humeroradial synostosis (HP:0003041) | 1.76765187 |
| 180 | Hypotrichosis (HP:0001006) | 1.76635379 |
| 181 | Hypoplasia of the pons (HP:0012110) | 1.76613509 |
| 182 | Palmar hyperkeratosis (HP:0010765) | 1.76093345 |
| 183 | Coronal craniosynostosis (HP:0004440) | 1.76025923 |
| 184 | Glioma (HP:0009733) | 1.71657009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.49604336 |
| 2 | BCKDK | 4.46977182 |
| 3 | EPHA2 | 3.67810409 |
| 4 | SIK1 | 3.53847780 |
| 5 | FGFR4 | 3.49877847 |
| 6 | CDC7 | 3.43392908 |
| 7 | TAF1 | 3.21769790 |
| 8 | MST1R | 3.10834589 |
| 9 | VRK2 | 3.09388704 |
| 10 | LATS1 | 3.05330530 |
| 11 | SMG1 | 2.99096951 |
| 12 | ZAK | 2.95056326 |
| 13 | TSSK6 | 2.72405978 |
| 14 | TNIK | 2.61507995 |
| 15 | BUB1 | 2.41108578 |
| 16 | ERBB4 | 2.38294301 |
| 17 | SRPK1 | 2.32246804 |
| 18 | PKN2 | 2.28183207 |
| 19 | MAP3K3 | 2.27926587 |
| 20 | FRK | 2.21780928 |
| 21 | PTK6 | 2.13896213 |
| 22 | MKNK2 | 2.02993628 |
| 23 | TRIB3 | 1.96991499 |
| 24 | PLK3 | 1.95492537 |
| 25 | CDK19 | 1.86895244 |
| 26 | MKNK1 | 1.80304435 |
| 27 | MAP3K9 | 1.61750482 |
| 28 | MET | 1.61687433 |
| 29 | MAP3K10 | 1.60217610 |
| 30 | NME1 | 1.59278355 |
| 31 | TYK2 | 1.57711846 |
| 32 | RIPK1 | 1.53255876 |
| 33 | FLT3 | 1.52821466 |
| 34 | TAOK3 | 1.51958493 |
| 35 | OXSR1 | 1.48894824 |
| 36 | PIK3CG | 1.48177220 |
| 37 | MAP2K3 | 1.46965122 |
| 38 | MAP3K11 | 1.43437825 |
| 39 | INSRR | 1.43204565 |
| 40 | CDK6 | 1.41426083 |
| 41 | VRK1 | 1.41094790 |
| 42 | STK38L | 1.37470354 |
| 43 | FER | 1.35568248 |
| 44 | PASK | 1.35342287 |
| 45 | LATS2 | 1.34351846 |
| 46 | EPHB2 | 1.32517976 |
| 47 | STK24 | 1.31050256 |
| 48 | DYRK2 | 1.30824383 |
| 49 | PTK2 | 1.28428735 |
| 50 | EPHB1 | 1.27401778 |
| 51 | MAP2K2 | 1.27125222 |
| 52 | ERBB2 | 1.26929590 |
| 53 | PLK1 | 1.26721874 |
| 54 | PBK | 1.25496624 |
| 55 | PLK4 | 1.24405960 |
| 56 | CAMK1G | 1.23600111 |
| 57 | FGFR2 | 1.22998021 |
| 58 | MAPK11 | 1.19897002 |
| 59 | NEK9 | 1.17233794 |
| 60 | MAP3K2 | 1.10187113 |
| 61 | WNK3 | 1.09691137 |
| 62 | RPS6KB2 | 1.05060682 |
| 63 | GRK6 | 1.04506594 |
| 64 | DYRK3 | 1.03331856 |
| 65 | ABL2 | 1.00976980 |
| 66 | BRSK2 | 0.99777407 |
| 67 | CHEK2 | 0.99494832 |
| 68 | KDR | 0.98702010 |
| 69 | NEK2 | 0.98200631 |
| 70 | EPHA3 | 0.96245567 |
| 71 | MAP2K4 | 0.93979094 |
| 72 | MAP3K7 | 0.90589858 |
| 73 | BMX | 0.89936909 |
| 74 | STK10 | 0.89678564 |
| 75 | ATR | 0.89173653 |
| 76 | FGFR1 | 0.89153737 |
| 77 | ALK | 0.88431853 |
| 78 | TTN | 0.88138618 |
| 79 | DYRK1B | 0.87178235 |
| 80 | MAPKAPK3 | 0.87013067 |
| 81 | CSNK1G1 | 0.85718310 |
| 82 | EIF2AK2 | 0.85348673 |
| 83 | CDK7 | 0.84101612 |
| 84 | JAK2 | 0.80997593 |
| 85 | TRIM28 | 0.79357781 |
| 86 | BRD4 | 0.79121127 |
| 87 | STK4 | 0.77245394 |
| 88 | TBK1 | 0.75288620 |
| 89 | CHEK1 | 0.74102627 |
| 90 | MAP3K8 | 0.73825921 |
| 91 | MTOR | 0.73537210 |
| 92 | JAK1 | 0.73072026 |
| 93 | LRRK2 | 0.72791709 |
| 94 | STK3 | 0.72321449 |
| 95 | PRKAA2 | 0.72059325 |
| 96 | DAPK2 | 0.72000737 |
| 97 | ATM | 0.71752705 |
| 98 | PAK4 | 0.70294760 |
| 99 | MAP2K6 | 0.70030163 |
| 100 | ACVR1B | 0.69694437 |
| 101 | TAOK1 | 0.69560267 |
| 102 | PRKCI | 0.67572593 |
| 103 | AURKB | 0.64542312 |
| 104 | GSK3A | 0.64195990 |
| 105 | MAPK15 | 0.63727953 |
| 106 | STK16 | 0.63332395 |
| 107 | MST4 | 0.63322697 |
| 108 | PDGFRA | 0.61420514 |
| 109 | MAP3K14 | 0.59369405 |
| 110 | TGFBR2 | 0.59092213 |
| 111 | PIM1 | 0.59068973 |
| 112 | MAP2K1 | 0.59008517 |
| 113 | WEE1 | 0.58429742 |
| 114 | RPS6KA4 | 0.58017190 |
| 115 | EIF2AK3 | 0.57514428 |
| 116 | FGFR3 | 0.56294907 |
| 117 | TGFBR1 | 0.56253210 |
| 118 | CDK4 | 0.53726966 |
| 119 | NUAK1 | 0.53256550 |
| 120 | CSNK1E | 0.52986285 |
| 121 | CSK | 0.50981329 |
| 122 | EEF2K | 0.48063585 |
| 123 | DAPK1 | 0.47666491 |
| 124 | CDK1 | 0.47414822 |
| 125 | CDK2 | 0.47391710 |
| 126 | GRK1 | 0.47337322 |
| 127 | DMPK | 0.46931586 |
| 128 | NEK1 | 0.46931378 |
| 129 | MAP3K1 | 0.46672875 |
| 130 | CDK12 | 0.46601467 |
| 131 | PAK2 | 0.45472687 |
| 132 | MAPK4 | 0.44777450 |
| 133 | TAOK2 | 0.43570854 |
| 134 | CAMK1D | 0.43226709 |
| 135 | STK39 | 0.41939144 |
| 136 | PRKDC | 0.41868080 |
| 137 | PRKG2 | 0.41284871 |
| 138 | PRKCZ | 0.40326497 |
| 139 | DDR2 | 0.38676801 |
| 140 | CASK | 0.38517912 |
| 141 | YES1 | 0.37870013 |
| 142 | CHUK | 0.35373440 |
| 143 | NLK | 0.34536011 |
| 144 | PRKACG | 0.33916299 |
| 145 | MAP3K5 | 0.33314294 |
| 146 | TYRO3 | 0.33046318 |
| 147 | MELK | 0.32463507 |
| 148 | CSNK2A1 | 0.31529580 |
| 149 | NEK6 | 0.30993298 |
| 150 | MUSK | 0.30949180 |
| 151 | CSNK2A2 | 0.30898916 |
| 152 | CSNK1D | 0.30660177 |
| 153 | TLK1 | 0.30628976 |
| 154 | CSNK1A1 | 0.30332509 |
| 155 | BMPR1B | 0.29957027 |
| 156 | EGFR | 0.29291737 |
| 157 | TESK1 | 0.29145362 |
| 158 | TIE1 | 0.28272391 |
| 159 | IRAK3 | 0.25851337 |
| 160 | AKT2 | 0.25604143 |
| 161 | IGF1R | 0.25434598 |
| 162 | RPS6KA1 | 0.25148434 |
| 163 | ICK | 0.25138207 |
| 164 | CAMK2G | 0.25115666 |
| 165 | TRPM7 | 0.23394715 |
| 166 | TTK | 0.21451197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09857863 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.53604476 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42617804 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18822929 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95829449 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.76034645 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.63307432 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.59298478 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59270662 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57876043 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.40809463 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39885379 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38977431 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38019661 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34622716 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34280087 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28277646 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.19364545 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13339308 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10552870 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06471882 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05174020 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98565776 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.97909195 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.89782218 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.89420771 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.89358862 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89209185 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84533894 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.82677995 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82646857 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78616216 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78112675 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.69983208 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.69845603 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68686616 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68597218 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67068742 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67014343 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64412181 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.63416992 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61988500 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.59486933 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53604913 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49622592 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47468956 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42566122 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42474213 |
| 49 | Proteasome_Homo sapiens_hsa03050 | 1.41598709 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35387979 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34517289 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33455784 |
| 53 | Cell cycle_Homo sapiens_hsa04110 | 1.32659530 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31380005 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31269526 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27599471 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27575846 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.25890700 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22023039 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19830366 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16827995 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15722367 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13809720 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09893047 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 1.04467482 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01276501 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01067031 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99738696 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92777680 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91436959 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90577856 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90097627 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89396881 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88557428 |
| 75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.87289669 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.86963909 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86232237 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.83436876 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83419278 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.82326340 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80468771 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78920983 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77849882 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72711541 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63856000 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62362031 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58852454 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57127016 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.55102163 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54818203 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54671179 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54035460 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52147974 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47364194 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46674385 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45659733 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40442141 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38912518 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38534996 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37785289 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.32901081 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32043784 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30959855 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.25158558 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23014966 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.22881943 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.15854652 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14452603 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11693140 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04232524 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03801016 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01919544 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01741198 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01738207 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.00068949 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.00010776 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.1382723 |
| 118 | Tight junction_Homo sapiens_hsa04530 | -0.1333226 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1314782 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | -0.1203185 |
| 121 | Pertussis_Homo sapiens_hsa05133 | -0.1107451 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1103294 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0962586 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0940155 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0566777 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | -0.0325614 |
| 127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0314595 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.0225086 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0131991 |

